According to the bulletin published on 8 November 2018 by the Finnish Medicines Agency Fimea, the summaries of product characteristics (SmPCs) of both human and veterinary medicines shall in the future be provided also in Swedish. This change is a part
EMA’s and HMA’s representatives brought interesting thoughts about the future priorities and presented the common strategy for European medicines regulatory network to 2020. The key priorities and challenges in addition to the global situation were sub
You are warmly welcome to Medical Device discussion event at Biocodex on 1st of November. Topic of the event: New EU Regulation of Medical Devices – What do these changes mean and how will they affect your company? WHERE| Biocodex Oy, Trio-talo.
You are warmly welcome to Medical Information discussion event at Biocodex on 6th of November. Topic of the event: How should GDPR be considered in the company’s medical information tasks? How to develop pharmaceutical information services suppo
You are warmly welcome to a whole-day seminar organized by our excellent experts in Good distribution practice (GDP) and Pharmacovigilance / Regulatory Affairs (PV/RA). Time: Tuesday 4th of September from 9.30 until 16.00 Location: Park Inn by Radisson
What is data integrity in Pharmaceutical industry? Learn this and many more from the latest summer issue of PHAME newsletter. Stay updated and subscribe PHAME newsletter from our website Next PHAME newsletter will be published on August. In the meanwhi
Summer holiday season is nearby. We would kindly remind you that we are available the whole summer season and our back-up system is in place. To ensure fluent and smooth information flow during holiday season, please use our common mailboxes whenever a
Biocodex Oy (former Algol Pharma) will move to new premises at Espoo Tapiola Spektri business park on 26th of April 2018. The new visiting address is: Biocodex Oy Metsänneidonkuja 8 02130 Espoo Finland and mail address: Biocodex Oy PL 52 02101 Espoo Fi
Algol Pharma is called Biocodex from the early October 2017. Biocodex is a multinational independent pharmaceutical company based in Paris. Algol Oy sold its subsidiary Algol Pharma to Biocodex in September 2016.
Medical Doctor Jaana Nurro has been appointed as Senior Medical Advisor at Algol Pharma one month ago. In addition to her strong clinical background she has almost a ten year experience from different medical functions within Pharmaceutical industry. A
We have upgraded our service offerings to response better to our customers’ needs. New services: Regulatory Intelligence – we will keep you up to date with changes in regulatory guidelines and amendments to legislation by monthly reports, covering the
We have already started planning of the events for 2017. We keep you updated and add details on dates and topics. Let’s go towards better learning in 2017! https://algolpharma.fi/pharmaceutical-services/training-services/
Algol Oy has sold its wholly-owned subsidiary Algol Pharma Oy to Biocodex S.A.S., a multinational specialty pharmaceutical company based in Paris, France. The divestment has been completed on September 9th. In future, the Algol Group will focus on business areas within the fields of chemicals and raw materials, technical products, maintenance and solutions as well as healthcare technology.